1. German Medical Association, National Association of Statutory Health Insurance Physicians, Association of the Scientific Medical Societies. National disease management guidelines programme: typ-2-diabetes mellitus – therapy. 2013. Available from:
http://www.leitlinien.de/nvl/diabetes/therapie
[Accessed 02th Feb 2015]
2. Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. NEJM. 2008;358(24):2545–59.
3. Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev. 2010;3:CD004371.
4. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.
5. U. K. Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703–13.